Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionCENTRAL TRUST Co
Latest Disclosed Ownership6,929 shares
Latest Disclosed Value $ 1,058,455
CENTRAL TRUST Co reports 0.87% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 17, 2026 - CENTRAL TRUST Co filed a 13F-HR form disclosing ownership of 6,929 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $1,058,405 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 6,990 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -0.87% during the quarter. The current value of the position is $995,420 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,929 -61 -0.87 1,058 9.87 0.0208
2026-02-02 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,990 -260 -3.59 964 3.66 0.0189
2025-11-06 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,250 -79 -1.08 930 4.85 0.0194
2025-08-07 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,329 0 0.00 887 8.45 0.0205
2025-04-18 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,329 256 3.62 817 18.75 0.0201
2025-01-24 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,073 5 0.07 688 -15.27 0.0169
2024-10-22 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,068 -318 -4.31 813 3.31 0.0190
2024-08-05 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,386 -249 -3.26 786 6.50 0.0193
2024-04-24 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,635 -510 -6.26 739 -10.22 0.0184
2024-01-24 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,145 70 0.87 822 0.00 0.0219
2023-10-26 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 8,075 -7 -0.09 823 0.86 0.0237
2023-07-26 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 8,082 355 4.59 816 14.79 0.0228
2023-04-19 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,727 270 3.62 711 5.03 0.0208
2023-01-26 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,457 76 1.03 676 20.50 0.0209
2022-11-17 2022-09-30 13F/A-2 NOVARTIS SPONSORED ADR 66987V109 7,381 -644 -8.02 561 -17.26 0.0192
2022-11-04 2022-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 8,025 0 678 0.0122
2022-11-03 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 8,025 0 678 0.0122
2022-08-09 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 8,025 -500 -5.87 678 -9.36 0.0224
2022-05-03 2022-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 8,525 136 1.62 748 1.91 0.0214
2022-02-08 2021-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 8,389 -94 -1.11 734 5.76 0.0207
2021-10-19 2021-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 8,483 -200 -2.30 694 -12.37 0.0247
2021-07-23 2021-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 8,683 200 2.36 792 9.24 0.0287
2021-04-23 2021-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 8,483 -1,874 -18.09 725 -25.87 0.0284
2021-01-29 2020-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 10,357 -461 -4.26 978 3.93 0.0400
2020-10-22 2020-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 10,818 -1,904 -14.97 941 -15.30 0.0426
2020-07-14 2020-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 12,722 -486 -3.68 1,111 2.02 0.0557
2020-04-17 2020-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 13,208 623 4.95 1,089 -8.64 0.0667
2020-01-21 2019-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 12,585 1,997 18.86 1,192 29.57 0.0610
2019-10-28 2019-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 10,588 728 7.38 920 3.37 0.0518
2019-07-12 2019-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 9,860 280 2.92 890 -3.37 0.0507
2019-04-26 2019-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 9,580 20 0.21 921 12.18 0.0549
2019-01-08 2018-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 9,560 -270 -2.75 821 -3.07 0.0546
2018-10-04 2018-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 9,830 -92 -0.93 847 12.93 0.0492
2018-07-09 2018-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 9,922 -3,222 -24.51 750 -29.38 0.0478
2018-04-04 2018-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 13,144 3,214 32.37 1,062 27.49 0.0674
2018-01-23 2017-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 9,930 -852 -7.90 833 -10.04 0.0507
2017-10-17 2017-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 10,782 103 0.96 926 3.93 0.0599
2017-07-14 2017-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 10,679 -2,253 -17.42 891 -7.28 0.0589
2017-04-06 2017-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 12,932 -113 -0.87 961 1.16 0.0640
2017-01-24 2016-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 13,045 188 1.46 950 -6.50 0.0654
2016-10-24 2016-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 12,857 38 0.30 1,016 -3.97 0.0741
2016-08-08 2016-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 12,819 452 3.65 1,058 18.08 0.0792
2016-04-11 2016-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 12,367 2,648 27.25 896 7.18 0.0707
2016-01-21 2015-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 9,719 161 1.68 836 -4.89 0.0690
2015-10-14 2015-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 9,558 -4 -0.04 879 -6.59 0.0765
2015-07-28 2015-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 9,562 -42 -0.44 941 -0.63 0.0740
2015-04-09 2015-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 9,604 -344 -3.46 947 2.82 0.0762
2015-01-16 2014-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 9,948 69 0.70 921 -0.97 0.0750
2014-10-23 2014-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 9,879 -637 -6.06 930 4.03 0.0739
2014-05-07 2014-03-31 13F NOVARTIS FOREIGN STOCK 66987V109 10,516 -719 -6.40 894 -1.00 0.0739
2014-01-27 2013-12-31 13F NOVARTIS FOREIGN STOCK 66987V109 11,235 -334 -2.89 903 1.69 0.0757
2013-10-24 2013-09-30 13F NOVARTIS FOREIGN STOCK 66987V109 11,569 -275 -2.32 888 6.09 0.0804
2013-08-13 2013-06-30 13F NOVARTIS FOREIGN STOCK 66987V109 11,844 11,844 837 0.0794
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.